NIP
RCKT icon

Nicholas Investment Partners’s Rocket Pharmaceuticals RCKT Stock Holding History

Nicholas Investment Partners’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-119,137
Closed -$3.21M – 230
2024
Q1 		$3.21M Buy
+119,137
New +$3.38M 0.33% 111

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nicholas Investment Partners's RCKT Position: Q2 2024 in Review

Nicholas Investment Partners sold out of Rocket Pharmaceuticals (RCKT) in Q2 2024, closing a stake of 119,137 shares — an estimated $3.21M sold.

Nicholas Investment Partners first reported a position in RCKT in Q1 2024 and held it in 1 quarter. The position peaked at $3.21M in Q1 2024. 178 funds tracked by Wall St. Rank hold RCKT as of Q2 2024.

  • Nicholas Investment Partners reported no remaining Rocket Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 119,137 Rocket Pharmaceuticals shares in Q2 2024, an estimated $3.21M.
  • Nicholas Investment Partners first reported a position in Rocket Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Nicholas Investment Partners's Rocket Pharmaceuticals position peaked at $3.21M in Q1 2024.
  • 178 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2024.

Based on Nicholas Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.